CRYOABLATION DEVICES FOR PAIN MANAGEMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Global Cryoablation Devices for Pain Management Market Size and Forecast – 2026-2033

The global cryoablation devices for pain management market is estimated to be valued at USD 658.99 Mn in 2026 and is expected to reach USD 973.33 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033. This steady growth is driven by increasing prevalence of chronic pain conditions, advancements in cryoablation technology, and growing preference for minimally invasive pain management solutions globally.

Key Takeaways of the Global Cryoablation Devices for Pain Management Market

• Cryoablation system segment is expected to lead the global cryoablation devices for pain management market, capturing 49.5% share in 2026.
• Nitrous oxide-based cryoneurolysis segment is estimated to represent 53.2% of the global cryoablation devices for pain management market share in 2026.
• Surgical pain segment is projected to dominate with 55.2% of the global cryoablation devices for pain management market share in 2026.
• North America is expected to lead the market, holding a share of 46.4% in 2026. Europe is anticipated to be the fastest-growing region, with 26.4% share in 2026.

Market Overview

• Global cryoablation devices for pain management market is gaining traction due to rising demand for non-opioid, minimally invasive pain treatment alternatives across chronic and procedure-related pain settings.
• The market is benefiting from stronger reimbursement support in the U.S. outpatient ecosystem.
• Chronic low back pain is opening a larger commercial opportunity for the market as cryoneurolysis begins to compete more directly with established interventional pain modalities. This broadens the addressable patient pool beyond niche nerve procedures and supports future product positioning in higher-volume pain segments.
• Technology development is moving toward more precise, image-guided, and workflow-integrated systems, which is raising performance expectations across the broader cryoablation space.

Currents Events and their Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Why Does the Cryoablation System Segment Dominate the Global Cryoablation Devices for Pain Management Market in 2026?

The cryoablation system segment is expected to hold the largest market share of 49.5% in 2026, owing to its advanced integration capabilities and broad clinical applications. Cryoablation systems are the complete systems that integrate the necessary equipment such as cryoprobes, control consoles, and monitoring interfaces into one system and therefore, it is possible to deliver and control the cryoneurolysis procedures with high precision. Such an integrated character makes them very desirable to health care professionals who seek to enhance the efficiency of processes and patient outcomes.

Such areas of development in this sector comprise technological advancements in system design, e.g., improvements in temperature control, compatibility with real-time imaging guidance and increased ease of use in the ergonomics of maneuvering by the physician. These are better than traditional methods in minimizing potential procedural complications and are more precise, thus being the choice of treatment in most types of pain management.

Moreover, there is a trend among healthcare facilities to perform surgeries with minimal invasiveness, shortened recovery time of patients and reduced length of stay, and the cryoablation systems perfectly fit the pattern since they provide specificity in nerve destruction by minimal collateral tissue destruction.

For instance, on March 11, 2026, IceCure Medical Ltd. announced that the U.S. Food and Drug Administration (FDA) approved the design of its “ChoICE” Trial Post-Market Study for the ProSense Cryoablation System in the local treatment of low-risk breast cancer.

(Source- IceCure Medical Ltd.)

Why Does the Nitrous Oxide-Based Cryoneurolysis Segment Dominate the Global Cryoablation Devices for Pain Management Market in 2026?

The nitrous oxide-based cryoneurolysis segment is expected to hold 53.2% of the market share in 2026, due to its proven safety profile and widespread clinical acceptance. Nitrous oxide is an excellent cryogen that provides appropriate subzero temperatures required to interfere with nerve functioning without permanent damage to nerve systems thereby making it a viable option in pain management therapy to reverse nerve modulation.

The balance that the technology provides between efficacy and patient safety is one of the key growth drivers of this technology. Controlled ablation with limited side effects achievable with nitrous oxide is more confidence-enhancing to the physician and expands the range of users, especially in out-patient and ambulatory care settings. Additionally, its gaseous form can be easily fine-tuned in terms of temperature and ablation region, enabling customization of treatments of more complicated nerve bundles or delicate anatomy.

For instance, in January 2025, Pacira BioSciences announced that the new iovera SmartTip was cleared by the U.S. FDA for long-lasting pain relief of the lumbar medial branch nerves, expanding the use of its nitrous oxide-based cryoneurolysis platform into chronic low back pain management. This is directly relevant to the Nitrous Oxide-Based Cryoneurolysis segment because iovera uses nitrous oxide to create the therapeutic cold zone for targeted nerve treatment.

(Source- Pacira BioSciences)

The Surgical Pain Segment Dominates the Global Cryoablation Devices for Pain Management Market

The surgical pain segment is expected to hold the largest market share of 55.2% in 2026, driven significantly by the increasing demand for effective perioperative pain control and advances in cryoablation techniques tailored for operative settings. Postoperative pain management is a highly sensitive issue in the work of surgeons and anesthesiologists, and cryoablation is a minimally invasive and targeted mechanism of nerve injury, which can eliminate the use of general analgesics and enhance recovery outcomes.

One of the main factors of this segment is the increasing knowledge about the positive effect of cryoablation to minimize opioid use after surgery, which in addition to minimizing the risk of addiction, reduces adverse side effects of using opioids. Such applications in surgical pain include thoracic surgeries like treatment of rib fracture, orthopedic surgeries, and abdominal surgeries that require localized pain management of the nerves. Cryoablation is especially appealing in the postoperative phase as the method has a good capacity to offer long-lasting analgesia without weakening of the muscles or loss of sensory functions.

Cryo-Based Pain Therapy Expands into High-Volume Indications

• Osteoarthritis is Becoming a Core Growth Area- Cryo-based pain treatment is increasingly becoming a more relevant product in osteoarthritis management as a way of healthcare providers seeking alternatives to opioid and minimally invasive methods when treating persistent joint pain. Its targeting of peripheral nerves and local pain relief properties are rendering it more appealing to musculoskeletal care particularly where patients are looking to avoid the recurrence of injections or drug-based therapy over the long term.
• Chronic Low Back Pain Opens a Larger Competitive Arena- Chronic low back pain is another issue of concern that cryo-based intervention opens up a larger competitive arena because it is a large patient base with an ever-present need to manage pain effectively. With the growing clinical interest in the procedures that provide specific relief with reduced systemic impact, the use of cryo-based technologies is being considered as an opportunity in the wider interventional route of pain management, providing the market with new growth opportunities.

Regional Insights

To learn more about this report, Download Free Sample

North America Cryoablation Devices for Pain Management Market Analysis and Trends

The North America region is projected to lead the market with a 46.4% share in 2026, driven by a well-established healthcare infrastructure, high adoption of advanced medical technologies, and favorable reimbursement policies. The market ecosystem enjoys the advantages of a rich research and an in-depth research and development activities with strong government support in terms of fund and regulation frameworks that hasten the approval of devices.

Furthermore, the fact that significant producers of medical equipment and a variety of specialized facilities in the field of pain management generate the need in cryoablation technologies contributes to its demand. The most prominent players in the market like Medtronic, Boston Scientific and Halyard Health have a strong presence in the region and they are developing new cryoablation equipment, which is specifically designed to treat chronic and acute pain. The advanced trade relations in North America also contribute to the efficient distribution and post sales services, which strengthens its leadership status.

For instance, in September 2025, AtriCure announced the commercial launch of its cryoXT device, designed to temporarily block pain by ablating peripheral nerves using controlled cryoablation technology. The device is specifically developed for post-operative pain management, including use cases such as amputation-related pain, where targeted nerve treatment is required.

(Source- AtriCure)

Europe Cryoablation Devices for Pain Management Market Analysis and Trends

The Europe region is expected to exhibit the fastest growth in the cryoablation devices for pain management market contributing 26.4% share in 2026, due to rapidly expanding healthcare infrastructure, increasing awareness of minimally invasive pain management therapies, and growing patient populations with chronic pain conditions. The market grows steadily, as Europe cryoablation devices used in pain management rely on more and more focus on minimally invasive and opioid-sparing pain treatment methods in the region. The increase in the burden of chronic pain, rising use of interventional procedures, and an improved clinical acceptance of cryoneurolysis as a treatment modality in musculoskeletal pain and neuropathic pain indicators are supporting demand.

Meanwhile, Europe is still a regulation-sensitive market and its EU MDR framework takes the entry barriers up and contributes to the increase of the adoption of more precise and clinically validated technologies that are based on cryo.

For instance, in October 2024, AtriCure announced the launch of its cryoSPHERE MAX probe, a new cryoablation probe developed for post-operative pain management. The company said the device is part of its cryoICE platform and is intended to temporarily block pain by ablating peripheral nerves.

(Source- AtriCure)

Cryoablation Devices for Pain Management Market Outlook for Key Countries

How is the U.S. Helping in the Growth of the Cryoablation Devices for Pain Management Market?

The U.S. cryoablation devices for pain management market for pain management is characterized by strong clinical research activity and broad clinical adoption in pain therapy. Major medical facilities are undertaking continuous clinical experiments with an aim of perfecting cryoablation procedures. Such companies as Medtronic and Boston Scientific also take up the scene with innovative system release and a wide range of products. The reimbursement models and insurance coverage are very reinforcing of the uptake of the procedure and therefore the U.S. is very vital in the innovation and commercialization of the technologies of cryoablation.

How is Germany Helping in the Growth of the Cryoablation Devices for Pain Management Market?

The existence of the strong healthcare system and presence of the major players in the industry like B. Braun Melsungen AG and AGA Medical contribute to the prosperous cryoablation devices for pain management market in Germany. The strict regulatory environment in the country gives high standards of products, which help in building confidence of the physicians and the safety of the patients. Good medical equipment export base and government aggressiveness in supporting medical technology research also adds value to making Germany one of the leading markets in Europe. The adoption of the cryoablation therapy in the routine and protocol of pain management is steadily increasing, with growing clinical evidence.

Key Drivers for the Growth of the China Cryoablation Devices for Pain Management Market

The cryoablation devices for pain management market in China is growing very fast due to government spending on health facilities and increased incidence of chronic pains due to an ageing population. Global device makers and local firms are collaborating in the country in higher numbers, which is boosting accessibility and localized products. Regulatory reforms have also helped the device approvals to be made faster thus increasing market penetration. The Xi an jianghua Medical Equipment is one of the companies that are driving forward by innovating with Chinese preference in mind.

Japan Cryoablation Devices for Pain Management Market Trends

The cryoablation devices for pain management market in Japan is supported by a well-developed and technologically advanced healthcare sector and a high demand among the patients to adopt minimally invasive pain management methods. The government promotes the use of new medical technologies by providing favorable policies. Such key players as Olympus Corporation and Terumo Corporation are influential in that they provide an innovative cryoablation solution, which is used in combination with other innovative approaches to pain management. The aging population of the country also stimulates the demand, whereas stringent clinical scrutiny promotes the adoption of the devices.

Stronger Push Toward Outpatient and Ambulatory Site-of-Care Expansion

• Shift Toward More Efficient Treatment Settings- The cryoablation devices for pain management market is gradually shifting towards outpatient and ambulatory care environments where health practitioners are focusing on quicker operations, cheaper treatment and improved patient flow. This change is opening a more conducive atmosphere under the cryoablation equipment since they are highly beneficial in minimally invasive surgeries that can be provided beyond the conventional inpatient hospitals.
• Market Impact on Cryoablation Device Adoption- With the ever-increasing effect of outpatient and ambulatory centers being involved in interventional pain management, there is growing demand to have devices that are easy to use, predictable in their integration into the workflow, and have efficient recovery mechanisms. The trend is anticipated to promote a wider embracement of cryoablation systems especially in those facilities that are interested in having a scalable pain treatment method that is non-opioid with great operational and economic potential.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• On March 02, 2026, Pacira BioSciences presented two real-world studies from its Innovations in Genicular Outcomes Registry (IGOR) at the American Academy of Orthopedic Surgeons 2026 Annual Meeting in New Orleans, held from March 2 to 6, 2026. The company said the registry is a multicenter, prospective, longitudinal observational program designed to generate real-world evidence on outcomes in knee osteoarthritis and related interventions.
• In July 2025, MicroPort EverPace, a subsidiary of MicroPort Scientific Corporation, announced that its full-suite IceMagic CryoAblation System had received European Union Medical Device Regulation (EU MDR) certification, marking a key regulatory milestone for commercialization in Europe.
• In November 2024, Boston Scientific closed its acquisition of Axonics, Inc., a medical technology company focused on devices for the treatment of urinary and bowel dysfunction. The transaction was valued at approximately USD 3.3 billion.

Top Strategies Followed by Global Cryoablation Devices for Pain Management Market Players

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Market Report Scope

Cryoablation Devices for Pain Management Market Report Coverage

Global Cryoablation Devices for Pain Management Market Dynamics

To learn more about this report, Download Free Sample

Global Cryoablation Devices for Pain Management Market Driver - Rising Prevalence of Chronic Pain Disorders

The growing number of cases of chronic pain disorder in the world greatly drives the use of cryoablation equipment in managing the pain. The older population and sedentary lifestyles coupled with the increase in lifestyle related diseases in the world are contributing to the prevalence of chronic pain conditions like neuropathic pain, arthritis and cancer related pain. Conventional methods of managing pain such as pharmaceutical use usually have a drawback of side effects, dependency, and insufficient long-term pain relief. The use of cryoablation equipment is a less invasive option that destroys nerves that detect pain signals by freezing them hence effective and long-lasting pain relief. It has rendered cryoablation interesting in the treatment of patients and medical caregivers seeking a less toxic and more effective means of managing pain.

For instance, in April 2024, AtriCure launched the cryoSPHERE+ probe as an expansion of its cryoICE platform for temporary ablation of peripheral nerves to block pain. The company said the probe was designed to support Cryo Nerve Block therapy, with a flexible, malleable shaft and a stronger, more durable distal tip intended to improve access and handling during procedures.

(Source- AtriCure)

Global Cryoablation Devices for Pain Management Market Opportunity - Expansion in Osteoarthritis and Musculoskeletal Pain Applications

The market for cryoablation devices used in pain management worldwide is going to gain greatly because of the growing usage of the cryoablation technology in the treatment of osteoarthritis and musculoskeletal pain. Osteoarthritis is a condition resulting in the degeneration of both the cartilage of the joint and the underlying bone and is one of the causes of chronic pain and disability, with millions of individuals all over the world having the condition.

Conventional methods of treatment are mainly based on pharmacologic approaches that can have side effects with prolonged usage, and therefore, there is a need to find effective and less invasive options like cryoablation. A more specific method, cryoablation devices, which utilize the effects of freezing temperature to interfere with the functionality of the nerve to deliver long-term pain relief, is a method that can be used to decrease the side effects on the system.

Analyst Opinion (Expert Opinion)

• Globally, the cryoablation devices for pain management market is growing due to increased demand in the minimally invasive and non-opioid pain management, the increased utilization of image guided procedures, and technological advances in the area of cry neurolysis. Hospitals and pain experts are seeking therapeutic solutions capable of enhancing recovery, lessening medication addiction, and nurturing focused pain treatment with reduced operating load. The market is also enjoying the effect of enhanced clinical familiarity and expanded discussion in the pain medicine and interventional care systems. Meanwhile, this is being aided by an increased interest in outpatient pain management and movement towards more patient friendly treatment pathways.
• However, there are still no barriers to the market. Physician training, procedure confidence and reimbursement clarity in different regions still play a major role in adoption. The generation of evidence is still relevant to broaden the use to more broad indications of pain and increase their ability to maintain long-term standing against substitute therapies. Conferences and medical meetings in the past few years have been significant in propelling awareness, knowledge transfer, and clinical exchange of cryo based pain interventions, and bringing the market away from a selected option towards a familiar therapeutic treatment. Altogether, the future perspective is positive, and the most promising prospects can be based on the enhanced use of technology, expanded procedural acceptance, and enhanced correspondence between clinical results and payment support.

Market Segmentation

• Product Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Cryoablation System
  • Cryoprobe
    • Disposable
    • Reusable
  • Accessories
• Technology Insights (Revenue, USD Mn, 2021 - 2033)
  • Nitrous Oxide-Based Cryoneurolysis
  • Carbon Dioxide-Based Cryoneurolysis
  • Others (Argon Gas-Based Cryoneurolysis, Liquid Nitrogen-Based Cryoneurolysis, etc.)
• Application Insights (Revenue, USD Mn, 2021 - 2033)
  • Surgical Pain
  • Nerve Pain
  • Cancer Pain
  • Others (Musco-skeletal Pain, etc.)
• End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others (Academic & Research Institutes, etc.)
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Pacira BioSciences
  • Epimed International
  • inomed Medizintechnik GmbH
  • Metrum Cryoflex
  • AtriCure
  • Medtronic
  • Boston Scientific Corporation
  • IceCure Medical
  • MicroPort Scientific Corporation
  • CPSI Biotech
  • Varian Medical Systems
  • CooperSurgical
  • Erbe Elektromedizin GmbH
  • HealthTronics
  • Sanarus Technologies
  • MicroPort EP MedTech

Sources

Primary Research Interviews

Industry Stakeholders list

• Cryoablation device manufacturers’ product managers
• Interventional pain specialists
• Anesthesiologists specializing in pain medicine
• Hospital procurement managers
• Ambulatory surgery center administrators
• Medical device distributors and channel partners

End-users list

• Pain management clinics
• Hospitals with interventional pain departments
• Ambulatory surgery centers
• Orthopedic specialty centers
• Oncology centers using palliative pain procedures
• Spine and neuromodulation treatment centers

Government and International Databases

• U.S. Food and Drug Administration (FDA)
• National Institutes of Health (NIH)
• World Health Organization (WHO)
• Centers for Medicare & Medicaid Services (CMS)
• Organization for Economic Co-operation and Development (OECD) Health Statistics
• World Bank Data

Trade Publications

• Pain Medicine News
• MD+DI
• Medical Device Network
• Fierce Biotech
• MedTech Dive
• Healthcare Purchasing News

Academic Journals

• Pain Medicine
• Regional Anesthesia & Pain Medicine
• Journal of Pain Research
• Anesthesiology
• The Clinical Journal of Pain
• Journal of Vascular and Interventional Radiology

Reputable Newspapers

• The Wall Street Journal
• Financial Times
• The New York Times
• The Guardian
• The Washington Post
• USA Today

Industry Associations

• International Association for the Study of Pain (IASP)
• American Society of Anesthesiologists (ASA)
• American Society of Regional Anesthesia and Pain Medicine (ASRA)
• Society of Interventional Radiology (SIR)
• Advanced Medical Technology Association (AdvaMed)
• European Society of Regional Anaesthesia & Pain Therapy (ESRA)

Public Domain Resources

• ClinicalTrials.gov
• MedlinePlus
• NIH RePORTER
• CDC Data and Statistics
• Eurostat

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 10 Years